Description:

Protocol Entry Form Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4068726B-4FD9-3FB9-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4068726B-4FD9-3FB9-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00382070 Registration - NSABP Test B42 Entry Form - 2707680v1.0

No Instruction available.

  1. StudyEvent: NSABP Test B42 Entry Form
    1. No Instruction available.
Test
Method of Payment (check all that apply)
Header
Race (Check all that apply)
Module 100
Race (Check all that apply)
Race
Race (Check all that apply)
Race
Race (Check all that apply)
Therapy Status
Did this patient receive any tamoxifen? (check all that apply)
Is the patient currently receiving an AI
Was the patient on the B-42 Letrozole Registration Program

Similar models